Unitree's $9 Billion IPO: China's First Humanoid Robot Listing Draws DeepSeek and State Backers
Unitree's $9 Billion IPO: China's First Humanoid Robot Listing Draws DeepSeek and State Backers
Chinese robotics maker Unitree has priced its initial public offering on Shanghai's STAR Market at 150.8 yuan (about $22.34) per share, implying a valuation of roughly 61 billion yuan, or about $9 billion. The listing marks a milestone for the country's robotics industry: Unitree becomes the first mainland-listed maker of humanoid robots, and its regulatory review moved unusually quickly, with reports describing a review period of somewhere between 73 and 104 days depending on the outlet. Many observers note that this pace reflects a broader push to fast-track approvals for companies regulators consider strategically important in hard tech.
Unitree Prices Landmark $9 Billion IPO
The offering sought to raise 6.1 billion yuan through the sale of approximately 40.44 to 40.45 million new shares, representing about 10% of the company's enlarged share capital. The size and speed of the listing have positioned Unitree as a bellwether for China's embodied-AI and robotics sector, which has seen a wave of companies moving toward public markets in recent months.
DeepSeek and State-Linked Investors Back the Listing
Among the strategic placement investors is DeepSeek's parent company, which reportedly took a stake of about 933,400 shares, equal to roughly 2.31% of the offering, for approximately 141 million yuan, subject to a three-year lockup period. Reported dollar figures for DeepSeek's investment vary across sources, with some describing it as roughly $20.8 million and others citing a considerably larger figure closer to $208 million. This discrepancy has not been fully reconciled across available reporting, and readers should treat the exact dollar amount with some caution until clarified.
Other strategic investors named in filings and reporting include Tencent, PetroChina (also referenced as CNPC), China Southern Power Grid, China Telecom, and the National Council for Social Security Fund. The presence of several state-linked entities on the investor roster suggests that Beijing views humanoid robotics and embodied AI as areas of national strategic interest, though the precise motivations behind each participant's involvement are not detailed in available disclosures.
Financials: Fast Growth, Thinning Margins
Unitree's overall 2025 revenue reportedly more than quadrupled to approximately 1.7 billion yuan. Humanoid robots generated about 867.8 million yuan in sales, overtaking four-legged robots to become the company's largest business segment for the first time. Some reports place 2025 net profit at around 591 million yuan, with gross margins above 60%.
More recent results point to a more complicated picture. First-quarter revenue for 2026 rose 68.5% to 422.8 million yuan, yet adjusted profit fell 52.6% to 40.3 million yuan over the same period. Guidance for the first half of 2026 varies depending on the source: some reports point to revenue growth of up to 45.4%, reaching roughly 1.1 billion yuan, alongside a potential profit decline of up to 22%, while others cite a narrower revenue range of 1.052 to 1.128 billion yuan and a profit range of 236 to 283 million yuan. The inconsistency likely reflects differing estimate methodologies or reporting windows rather than contradictory underlying facts, but it underscores that near-term profitability trends remain unsettled even as top-line growth continues.
Investor appetite for the offering appears to have been strong: the institutional offline tranche was reportedly oversubscribed by more than 2,600 times, a figure that points to significant speculative demand surrounding the listing.
A Sector Racing to List Before a Shakeout
Unitree's debut is part of a broader pattern of embodied-AI and robotics startups moving toward public listings. A recurring theme in coverage of the sector is the sense that companies are racing to secure capital and public valuations before an anticipated period of industry consolidation. Rivals such as UBTech and Shenzhen Dobot post respectable gross margins, in the high 30s to mid 40s percent range, but both reportedly remain unprofitable, raising open questions about the near-term financial sustainability of the wider humanoid and embodied-AI robotics category.
Geopolitical Exposure: U.S. Market Access and Export Controls
Unitree's growth story is unfolding against a backdrop of ongoing U.S.-China trade and technology tensions. U.S. sales reportedly accounted for about 13.3% of the company's revenue in the prior year, a meaningful but not dominant share of its business. Several reports note that new U.S. regulatory measures targeting foreign-made humanoid and quadruped robots could affect Unitree's future access to American customers, though the precise scope and enforcement of such restrictions remains an evolving situation.
A recurring concern raised in coverage is Unitree's dependency on imported components, which leaves the company exposed to export controls tied to the broader technology rivalry between Washington and Beijing. Some industry watchers frame this dynamic as a risk factor for Unitree's international growth ambitions, while others note that the company's primary revenue base remains domestic, which may cushion the near-term impact of any U.S. policy shifts. As with much of the geopolitical framing around Chinese tech IPOs, the ultimate effect on Unitree's business will likely depend on how trade policy develops in the coming months.